Current filters:

Indinavir Sulfate

1 to 9 of 106 results

Merck & Co cuts HIV AIDS drug prices 22%


Five years after the launch of its global HIV/AIDS drug pricing policy, USA-based drug major Merck &…

CrixivanEfavirenzIndinavir SulfateMerck KGaASustiva

Tipranavir more effective than lopinavir in HIV, study finds


New data from multiple analyses presented at the Conference on Retroviruses and Opportunistic Infections…

Abbott LaboratoriesAptivusBoehringer IngelheimCrixivanGlaxoSmithKlineGSKIndinavir SulfateInviraseMerck KGaARocheSaquinavir MesylateTipranavir

MaxCmin 1 trial in favor of saquinavir


The final results of the 317-patient MaxCmin 1 trial comparing two"boosted" HIV protease inhibitor regimens…

Abbott LaboratoriesCrixivanIndinavir SulfateMerck KGaARoche

CPMP backs new schedule for Roche HIV drug


Europe's Committee for Proprietary Medicinal Products has granted apositive opinion for Roche's Invirase…

Abbott LaboratoriesCrixivanIndinavir SulfateInviraseMerck KGaANorvirOral SolutionRitonavir CapsulesRocheSaquinavir Mesylate

Brazil to step up HIV/ AIDS vaccine R&D


Brazil plans to place greater emphasis on R&D into a vaccine forHIV/AIDS this year, and also to increase…

Abbott LaboratoriesCrixivanEfavirenzIndinavir SulfateMerck KGaAnelfinavirNorvirOral SolutionRitonavir CapsulesRocheSustivaViracept

1 to 9 of 106 results

Back to top